Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCity Lon Inv Regulatory News (CLIG)

Share Price Information for City Lon Inv (CLIG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 370.00
Bid: 365.00
Ask: 380.00
Change: 5.00 (1.37%)
Spread: 15.00 (4.11%)
Open: 356.00
High: 380.00
Low: 356.00
Prev. Close: 365.00
CLIG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Letter to icapital.biz Berhad

15 Sep 2016 09:46

RNS Number : 9378J
City of London Investment Group PLC
15 September 2016
 

CITY OF LONDON INVESTMENT GROUP PLC

 

TEXT OF LETTER TO ICAPITAL.BIZ BERHAD

 

(LONDON, 15 September, 2016) - City of London Investment Management has sent a letter (published in full below) to the board of icapital.biz Berhad (ICAP:MK) explaining its intention to oppose the re-election of directors at ICAP's forthcoming AGM.

 

Background

City of London Investment Group is an emerging markets fund manager which specialises in investing in closed-end investment companies. The firm is authorised and regulated by the Financial Conduct Authority and registered as an Investment Advisor with the Securities and Exchange Commission.

 

 

For further information, please contact:

 

Simon Westlake

City of London Investment Group

020 7711 1552

simon.westlake@citlon.co.uk 

 

 

Full text of letter

 

 

The Directors

icapital.biz Berhad

Unit 30-01, Level 30, Tower A

Vertical Business Suite

Avenue 3, Bangsar South

No. 8, Jalan Kerinchi

59200 Kuala Lumpur

Malaysia

 

 

15th September 2016

 

 

Dear Directors,

 

Twelfth Annual General Meeting of icapital.biz Berhad (ICAP)

 

Clients of City of London Investment Management Limited (CLIM) own 21,970,900 ICAP shares (15.7%). There has been no action in response to any of the points that were raised in our letter to you dated 26th August 2015, which set out our concerns regarding ICAP's poor performance and persistently wide discount to NAV. CLIM therefore confirms that it intends to continue voting against the re-election of incumbent directors. Accordingly, CLIM intends to vote against the re-election of Madam Leong So Seh at ICAP's 12th AGM on Saturday, 24th September 2016.

 

 

· Performance

We reiterate our call for performance comparisons in shareholder communications to be made on a total return basis, which is universally accepted in the investment industry as best practice.

 

The total return in the five years to end May 2016 for the FTSE Bursa Malaysia Index has been 23.1% cumulative (equivalent to 4.2% pa). In comparison ICAP's NAV return has been 13.0% cumulative (2.5% pa). The share price return over this period has been even worse due to discount widening, at 6.4% cumulative (1.3% pa). These performance figures have been sourced from Bloomberg.

 

The Chairman stated, in his letter to shareholders, dated 19th July 2016, that ICAP has 'performed beyond expectations'. We wish to make clear that ICAP's performance over the past five years has fallen significantly short of our own expectations.

 

· Cash Management

We note the continued extraordinarily high cash level, which has persisted at over 50% for 3 years and on which shareholders have been paying fees for fund management and investment research services. Cash at each calendar year end since ICAP was launched (31 December 2005 to 31 December 2015) has averaged 39%. ICAP is clearly operating with surplus cash which, in our opinion should be returned to shareholders.

 

· Expense Ratio

ICAP's expense ratio in 2016 was 1.9% (2015: 1.9%) which compares unfavourably with other country specific closed-end funds. The most significant item is the aggregate 1.5% incurred for fund management and investment research. CLIM urges the Board to negotiate competitive fees in order to reduce the expense ratio to an acceptable level.

 

· Discount Control

ICAP's prospectus dated 26 September 2005 explained clearly that the return for closed-end fund investors is a product of NAV performance and the discount movement. The Chairman's letter to Shareholders in the 2016 Annual Report refers to a 4% rise in ICAP's NAV for the 12 months ended 31 May 2016. However it does not mention that the share price actually declined over this period, because the discount widened. The discount averaged 22% in 2016 versus 20% in 2015 (source: Bloomberg). Neither the level nor the trend is acceptable and CLIM is disappointed that the Board has again failed to take any action to address this problem.

 

CLIM notes from the 2016 Annual Report the Board's deliberations on 27th July 2015 regarding share buy-backs and the accompanying statement that the "Fund's NAV could deteriorate if it uses its available fund to purchase own shares". Repurchasing shares at a discount to NAV will actually increase the NAV per share and in CLIM's opinion this would be a sensible use of ICAP's cash, particularly in view of the Manager's apparent shortage of investment ideas.

 

ICAP's prospectus included a section (6.7, page 64) on managing discounts, noting that the options available include 'share repurchase, open-ending, takeover, liquidation'. CLIM urges the Board to consider all these options and to formulate a strategy to reduce the discount from its present unacceptable level.

 

 

 

Yours sincerely,

 

Simon Westlake

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAGGUGWBUPQURA
Date   Source Headline
21st Jan 20193:50 pmEQSHardman & Co Research: City of London Investment Group (CLIG): Solid FUM update offset by margin changes
16th Jan 20197:00 amRNSFUNDS UNDER MANAGEMENT - Trading Update
30th Oct 20184:48 pmRNSDirector/PDMR Shareholding
30th Oct 20184:47 pmRNSDirector/PDMR Shareholding
30th Oct 20184:46 pmRNSDirector/PDMR Shareholding
22nd Oct 20183:27 pmRNSResult of AGM
17th Oct 201811:37 amRNSHolding(s) in Company
9th Oct 20183:05 pmEQSHardman & Co Research: City of London Investment Group (CLIG): Solid FUM update offset by margin changes
8th Oct 20187:00 amRNSTrading Update - 1st Quarter FuM
25th Sep 201811:17 amRNSHolding(s) in Company
25th Sep 20187:00 amRNSDirector/PDMR Shareholding
20th Sep 20181:46 pmEQSHardman & Co Research: City of London Investment Group (CLIG): Strengthening cash position to boost returns
17th Sep 20183:15 pmRNSFinal Results - Replacement
17th Sep 20187:00 amRNSInterim Results
14th Aug 20183:39 pmRNSTEXT OF LETTER TO LAZARD WORLD TRUST FUND
9th Aug 20182:58 pmRNSShare Buyback and Total Voting Rights
17th Jul 201810:55 amEQSHardman & Co Research: City of London Investment Group (CLIG): Dividend increase boosts yield
17th Jul 20187:00 amRNSTrading Update
11th Jul 201811:39 amRNSDirector Declaration
4th Jul 20183:48 pmRNSHolding(s) in Company
14th Jun 201811:25 amRNSHolding(s) in Company
29th May 20184:57 pmRNSHolding(s) in Company
10th May 20185:25 pmRNSHolding(s) in Company
1st May 20187:00 amRNSBoard Changes
25th Apr 20184:34 pmRNSHolding(s) in Company
18th Apr 20187:00 amRNSInterim Management Statement / Trading Update
3rd Apr 20184:03 pmRNSHolding(s) in Company
23rd Mar 20189:46 amRNSDirector/PDMR Shareholding
14th Mar 20183:41 pmRNSDirector/PDMR Shareholding
19th Feb 20187:00 amRNSInterim Results
18th Jan 201810:02 amRNSNew Directorship notification Listing Rule 9.6.14
17th Jan 20187:00 amRNSTrading Update
21st Dec 20172:24 pmRNSHolding(s) in Company
8th Dec 20176:36 pmRNSHolding(s) in Company
6th Dec 20175:25 pmRNSRESPONSE TO ICAP:MK RE MAX SHAREHOLDING
13th Nov 201711:22 amRNSHolding(s) in Company
8th Nov 20172:58 pmRNSDirector/PDMR Shareholding
8th Nov 20172:50 pmRNSDirector/PDMR Shareholding
8th Nov 20172:45 pmRNSDirector/PDMR Shareholding
24th Oct 201711:55 amRNSDirector/PDMR Shareholding
23rd Oct 20172:36 pmRNSResult of AGM
18th Oct 20179:34 amRNSHolding(s) in Company
17th Oct 201711:37 amRNSDirector/PDMR Shareholding
12th Oct 20179:51 amRNSDirector/PDMR Shareholding
11th Oct 20173:07 pmRNSDirector/PDMR Shareholding
10th Oct 20175:27 pmRNSHolding(s) in Company
10th Oct 201712:20 pmRNSDirector/PDMR Shareholding
9th Oct 20177:00 amRNSAGM Trading Update
3rd Oct 20174:12 pmRNSHolding(s) in Company
28th Sep 20174:30 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.